Fig. 3From: HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistryA combination of HER2 IHC and HER2 amplification status by NGS sequence in a cost-effective HER2 test strategyBack to article page